Matches in Wikidata for { <http://www.wikidata.org/entity/Q57274821> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q57274821 description "article scientifique publié en 2000" @default.
- Q57274821 description "article" @default.
- Q57274821 description "im Dezember 2000 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57274821 description "wetenschappelijk artikel" @default.
- Q57274821 description "наукова стаття, опублікована в грудні 2000" @default.
- Q57274821 description "հոդված" @default.
- Q57274821 description "مقالة علمية تنشرت ف 1 دجنبر 2000" @default.
- Q57274821 name "ANDROGEN RECEPTOR GENE AMPLIFICATION AT PRIMARY PROGRESSION PREDICTS RESPONSE TO COMBINED ANDROGEN BLOCKADE AS SECOND LINE THERAPY FOR ADVANCED PROSTATE CANCER" @default.
- Q57274821 name "ANDROGEN RECEPTOR GENE AMPLIFICATION AT PRIMARY PROGRESSION PREDICTS RESPONSE TO COMBINED ANDROGEN BLOCKADE AS SECOND LINE THERAPY FOR ADVANCED PROSTATE CANCER" @default.
- Q57274821 type Item @default.
- Q57274821 label "ANDROGEN RECEPTOR GENE AMPLIFICATION AT PRIMARY PROGRESSION PREDICTS RESPONSE TO COMBINED ANDROGEN BLOCKADE AS SECOND LINE THERAPY FOR ADVANCED PROSTATE CANCER" @default.
- Q57274821 label "ANDROGEN RECEPTOR GENE AMPLIFICATION AT PRIMARY PROGRESSION PREDICTS RESPONSE TO COMBINED ANDROGEN BLOCKADE AS SECOND LINE THERAPY FOR ADVANCED PROSTATE CANCER" @default.
- Q57274821 prefLabel "ANDROGEN RECEPTOR GENE AMPLIFICATION AT PRIMARY PROGRESSION PREDICTS RESPONSE TO COMBINED ANDROGEN BLOCKADE AS SECOND LINE THERAPY FOR ADVANCED PROSTATE CANCER" @default.
- Q57274821 prefLabel "ANDROGEN RECEPTOR GENE AMPLIFICATION AT PRIMARY PROGRESSION PREDICTS RESPONSE TO COMBINED ANDROGEN BLOCKADE AS SECOND LINE THERAPY FOR ADVANCED PROSTATE CANCER" @default.
- Q57274821 P1433 Q57274821-59215CFA-7F50-45F6-B7AF-EFD44310CFF7 @default.
- Q57274821 P1476 Q57274821-93C9F13A-B467-4C26-BF23-05BC8EA42AD3 @default.
- Q57274821 P2093 Q57274821-6E22642D-95BE-4760-ACB5-DD7EA3A60F6A @default.
- Q57274821 P2093 Q57274821-7830D5C0-F01C-435D-ACFB-691469E67EC6 @default.
- Q57274821 P2093 Q57274821-C0B606B3-C303-4054-9EE7-B5C680A07CEA @default.
- Q57274821 P304 Q57274821-06E3BBA6-25A7-444D-B98B-54ACA06DB719 @default.
- Q57274821 P31 Q57274821-861BC6A1-5588-47E7-9749-7008645B4E8D @default.
- Q57274821 P356 Q57274821-92889C98-AC14-4081-A644-C4D3D92AAAA9 @default.
- Q57274821 P407 Q57274821-B66165D6-7900-4F7C-A7E2-0A70AF56F813 @default.
- Q57274821 P433 Q57274821-1284A669-E566-4374-B272-35E23A05B5DC @default.
- Q57274821 P478 Q57274821-DD00D2AD-041E-4223-868D-A93AC8249C29 @default.
- Q57274821 P50 Q57274821-12F3F8E0-B323-4F34-ADFC-0A379D689FFF @default.
- Q57274821 P50 Q57274821-2D524268-AB8B-41E6-BAF6-5D177A059C7F @default.
- Q57274821 P50 Q57274821-4BB7FCC7-87EE-47FA-BB6B-F3128AFC47A3 @default.
- Q57274821 P577 Q57274821-F4F1927E-9655-46D7-B5AE-5B4CFF56FC5E @default.
- Q57274821 P698 Q57274821-45911227-AA02-4443-B922-A2B6543F5FE9 @default.
- Q57274821 P921 Q57274821-89B8B31E-7CCC-4A82-A3BA-AECEC9D1D792 @default.
- Q57274821 P356 S0022-5347(05)66935-2 @default.
- Q57274821 P698 11061898 @default.
- Q57274821 P1433 Q15709979 @default.
- Q57274821 P1476 "Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer" @default.
- Q57274821 P2093 "Koivisto P" @default.
- Q57274821 P2093 "Palmberg C" @default.
- Q57274821 P2093 "Tammela TL" @default.
- Q57274821 P304 "1992-1995" @default.
- Q57274821 P31 Q13442814 @default.
- Q57274821 P356 "10.1016/S0022-5347(05)66935-2" @default.
- Q57274821 P407 Q1860 @default.
- Q57274821 P433 "6" @default.
- Q57274821 P478 "164" @default.
- Q57274821 P50 Q29949182 @default.
- Q57274821 P50 Q49957442 @default.
- Q57274821 P50 Q60731091 @default.
- Q57274821 P577 "2000-12-01T00:00:00Z" @default.
- Q57274821 P698 "11061898" @default.
- Q57274821 P921 Q181257 @default.